Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 6 Jun 2002 |
| Genmab, Genmab completes accrual in HuMax-IL15 phase I/II-study | 30 May 2002 |
| Genmab, GENMAB AND ACE BIOSCIENCES COLLABORATE TO TREAT INFECTIOUS DISEASE | 13 May 2002 |
| Genmab, appoints VP manufacturing | 29 Apr 2002 |
| Genmab, 1st quarterly report 2002 | 15 Apr 2002 |